Matthew S. Forsyth
CIK: 0002120002
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TMDX
TransMedics Group, Inc.
Officer
Discretionary Trading P&L
Holdings
About Forsyth Matthew S.
Forsyth Matthew S. (SEC CIK 0002120002) files insider reports with the SEC as Officer of TransMedics Group, Inc. (TMDX).
Signal8 holds 2 ownership filings by Forsyth Matthew S. (1 Form 3, 1 Form 4), filed between Mar 13, 2026 and May 21, 2026. Those filings report 1 transaction, the latest on May 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Forsyth Matthew S.'s filings is in ANDOVER, MA.
Recent filings by Forsyth Matthew S.
- May 19, 2026: Grant or award of TMDX shares (Form 4, code A).
Other insiders filing for TransMedics Group, Inc. (TMDX)
- Araujo Fernando N.
- Weill David, Director
- TOBIN JAMES R, Director
- Corcoran Nicholas
- Hernandez Gerardo, Chief Financial Officer
- Hassanein Waleed H, President & CEO